Literature DB >> 25083869

p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.

Darjus F Tschaharganeh1, Wen Xue2, Diego F Calvisi3, Matthias Evert3, Tatyana V Michurina2, Lukas E Dow1, Ana Banito1, Sarah F Katz4, Edward R Kastenhuber1, Susann Weissmueller5, Chun-Hao Huang1, Andre Lechel4, Jesper B Andersen6, David Capper7, Lars Zender2, Thomas Longerich8, Grigori Enikolopov2, Scott W Lowe9.   

Abstract

The p53 tumor suppressor coordinates a series of antiproliferative responses that restrict the expansion of malignant cells, and as a consequence, p53 is lost or mutated in the majority of human cancers. Here, we show that p53 restricts expression of the stem and progenitor-cell-associated protein nestin in an Sp1/3 transcription-factor-dependent manner and that Nestin is required for tumor initiation in vivo. Moreover, loss of p53 facilitates dedifferentiation of mature hepatocytes into nestin-positive progenitor-like cells, which are poised to differentiate into hepatocellular carcinomas (HCCs) or cholangiocarcinomas (CCs) in response to lineage-specific mutations that target Wnt and Notch signaling, respectively. Many human HCCs and CCs show elevated nestin expression, which correlates with p53 loss of function and is associated with decreased patient survival. Therefore, transcriptional repression of Nestin by p53 restricts cellular plasticity and tumorigenesis in liver cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25083869      PMCID: PMC4221237          DOI: 10.1016/j.cell.2014.05.051

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  56 in total

Review 1.  Transcriptional repression mediated by the p53 tumour suppressor.

Authors:  J Ho; S Benchimol
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

2.  Expression of nestin-green fluorescent protein transgene marks oval cells in the adult liver.

Authors:  Anatoli S Gleiberman; Juan M Encinas; John L Mignone; Tatyana Michurina; Michael G Rosenfeld; Grigori Enikolopov
Journal:  Dev Dyn       Date:  2005-10       Impact factor: 3.780

3.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  Molecular classification of prostate cancer using curated expression signatures.

Authors:  Elke K Markert; Hideaki Mizuno; Alexei Vazquez; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target.

Authors:  Anna Saborowski; Michael Saborowski; Monika A Davare; Brian J Druker; David S Klimstra; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

7.  Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis.

Authors:  Wen Jing Lu; Feng Lan; Qihua He; Andrew Lee; Chad Z Tang; Lin Dong; Baojin Lan; Xiaowen Ma; Joseph C Wu; Li Shen
Journal:  Int J Cancer       Date:  2010-07-28       Impact factor: 7.396

8.  Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter.

Authors:  Da Yong Wu; Zhen Yao
Journal:  Cell Res       Date:  2006-03       Impact factor: 25.617

9.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  87 in total

1.  Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.

Authors:  Ruidong Xue; Lu Chen; Chong Zhang; Masashi Fujita; Ruoyan Li; Shu-Mei Yan; Choon Kiat Ong; Xiwen Liao; Qiang Gao; Shota Sasagawa; Yanmeng Li; Jincheng Wang; Hua Guo; Qi-Tao Huang; Qian Zhong; Jing Tan; Lisha Qi; Wenchen Gong; Zhixian Hong; Meng Li; Jingmin Zhao; Tao Peng; Yinying Lu; Kiat Hon Tony Lim; Arnoud Boot; Atushi Ono; Kazuaki Chayama; Zemin Zhang; Steve George Rozen; Bin Tean Teh; Xin Wei Wang; Hidewaki Nakagawa; Mu-Sheng Zeng; Fan Bai; Ning Zhang
Journal:  Cancer Cell       Date:  2019-05-23       Impact factor: 31.743

2.  Comparing stemness gene expression between stem cell subpopulations from peripheral blood and adipose tissue.

Authors:  Maria Teresa González-Garza; Delia E Cruz-Vega; Alejandro Cárdenas-Lopez; Rosa Maria de la Rosa; Jorge E Moreno-Cuevas
Journal:  Am J Stem Cells       Date:  2018-06-01

3.  p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.

Authors:  Sung-Hwan Moon; Chun-Hao Huang; Shauna L Houlihan; Kausik Regunath; William A Freed-Pastor; John P Morris; Darjus F Tschaharganeh; Edward R Kastenhuber; Anthony M Barsotti; Rachel Culp-Hill; Wen Xue; Yu-Jui Ho; Timour Baslan; Xiang Li; Allison Mayle; Elisa de Stanchina; Lars Zender; David R Tong; Angelo D'Alessandro; Scott W Lowe; Carol Prives
Journal:  Cell       Date:  2018-12-20       Impact factor: 41.582

Review 4.  p53 in liver pathologies-taking the good with the bad.

Authors:  Meital Charni; Noa Rivlin; Alina Molchadsky; Ronit Aloni-Grinstein; Varda Rotter
Journal:  J Mol Med (Berl)       Date:  2014-11-19       Impact factor: 4.599

5.  Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels.

Authors:  Shogo Tajima; Michihiko Waki; Tomonori Tsuchiya; Shoji Hoshi
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

6.  DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.

Authors:  Edward R Kastenhuber; Gadi Lalazar; Shauna L Houlihan; Darjus F Tschaharganeh; Timour Baslan; Chi-Chao Chen; David Requena; Sha Tian; Benedikt Bosbach; John E Wilkinson; Sanford M Simon; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-21       Impact factor: 11.205

Review 7.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

8.  Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma.

Authors:  Margaret A Hill; William B Alexander; Bing Guo; Yasutaka Kato; Krushna Patra; Michael R O'Dell; Matthew N McCall; Christa L Whitney-Miller; Nabeel Bardeesy; Aram F Hezel
Journal:  Cancer Res       Date:  2018-06-05       Impact factor: 12.701

9.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

Review 10.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.